Repaglinide for adolescents with cystic fibrosis-related diabetes
Withdrawn prior to enrolment
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 11 Mar 2015
At a glance
- Drugs Repaglinide (Primary) ; Insulin
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 14 Feb 2008 The expected completion date for this trial is now 1 Aug 2007.
- 16 Nov 2007 Status changed from initiated to discontinued (unable to recruit any patients).